COURTNEY MOORE: Open Payments
NPI 1942816061 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,799 in 29 payments from 9 companies in 2025. Trend: 2023 $1,761 · 2024 $872 · 2025 $17,799
Consulting: $11,375Travel & lodging: $4,728Food & beverage: $1,389Speaker / faculty: $308
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $16,410 |
| E.R. Squibb & Sons, L.L.C. | 5 | $504 |
| AstraZeneca Pharmaceuticals LP | 3 | $348 |
| BeOne Medicines USA, Inc. | 1 | $150 |
| Iovance Biotherapeutics, Inc. | 1 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $101 |
| Ipsen Biopharmaceuticals, Inc | 1 | $93 |
| Merck Sharp & Dohme LLC | 1 | $74 |
| ARRAY BIOPHARMA INC | 1 | $3 |
Products named: IBRANCE, OPDIVO, IMFINZI, BRUKINSA, COBENFY, REBLOZYL, Amtagvi, FRUZAQLA.
Industry payments across KY — which companies pay providers there.
